Top Commentary Stories
Cost-Containment
New treatments for people with a rare form of heart failure are in the pipeline
By Andy SzczotkaFor employers' health plans, the new ATTR-CM specialty drugs could cost $500,000 per participant treated.
For employers' health plans, the new ATTR-CM specialty drugs could cost $500,000 per participant treated.